CRW.L

Craneware Plc
Craneware plc - Result of AGM
13th November 2024, 13:23
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 1281M
Craneware plc
13 November 2024
 

Craneware plc

 

Result of AGM

 

13 November 2024 - Craneware plc (AIM: CRW.L), the market leader in Value Cycle software solutions for the US healthcare market, is pleased to announce that at its Annual General Meeting held earlier today, all resolutions were duly passed.

 

The voting results are included below:  

 

Resolution

For

Against

Withheld

Total

01

24,014,251

34,459

15,762

24,064,472

02

23,767,556

295,085

1,831

24,064,472

03

23,932,456

127,058

4,958

24,064,472

04

23,986,686

76,082

1,704

24,064,472

05

23,983,610

79,158

1,704

24,064,472

06

23,985,655

76,082

2,735

24,064,472

07

23,994,942

67,826

1,704

24,064,472

08

23,617,067

445,700

1,705

24,064,472

09

23,994,941

67,827

1,704

24,064,472

10

24,064,298

26

148

24,064,472

11

22,044,690

2,018,674

1,108

24,064,472

12

23,655,931

408,133

408

24,064,472

13

23,326,644

731,077

6,751

24,064,472

14

23,056,060

1,001,661

6,751

24,064,472

15

21,080,491

282,911

2,701,070

24,064,472

 

 

For further information, please contact:

 

Craneware plc

+44 (0)131 550 3100

Keith Neilson, CEO


Craig Preston, CFO


 


Alma Strategic Communications (Financial PR)

+44 (0)20 3405 0205

Caroline Forde, Kinvara Verdon, Sarah Peters

craneware@almastrategic.com

 


Peel Hunt (NOMAD and Joint Broker) 

+44 (0)20 7418 8900

Neil Patel, Benjamin Cryer, Kate Bannatyne


 


Investec Bank PLC (Joint Broker)

+44 (0)20 7597 5970

Patrick Robb, Virginia Bull, Shalin Bhamra


  

 

Berenberg (Joint Broker)

+44 (0)20 3207 7800

Mark Whitmore, Richard Andrews, Dan Gee-Summons


 

About Craneware

 

The Craneware Group (AIM:CRW.L), is the market leader in value cycle solutions. For 25 years, we have collaborated with U.S. healthcare providers to optimize revenue integrity, pricing intelligence, decision support, labor productivity, business of pharmacy, and 340B program management. 

 

Customers choose Trisus®, a HITRUST- and SOC2 Type II-certified, SaaS platform, to achieve operational and financial excellence in pursuit of their healthcare mission - delivering quality care to their communities. The Craneware Group - Transforming the Business of Healthcare.

 

Learn more at www.thecranewaregroup.com

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGBXBDBDDBDGSX]]>
TwitterFacebookLinkedIn